# Tacrolimus as Treatment of Breast Cancer-Related Lymphedema

> **NCT04541290** · PHASE1,PHASE2 · COMPLETED · sponsor: **Odense University Hospital** · enrollment: 20 (actual)

## Conditions studied

- Breast Cancer Lymphedema

## Interventions

- **DRUG:** Protopic 0.1 % Topical Ointment

## Key facts

- **NCT ID:** NCT04541290
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-22
- **Primary completion:** 2022-01-06
- **Final completion:** 2022-01-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04541290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04541290, "Tacrolimus as Treatment of Breast Cancer-Related Lymphedema". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT04541290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*